首页 | 官方网站   微博 | 高级检索  
     

蝶窦原发恶性肿瘤16例治疗分析
引用本文:刘志萍,罗京伟,徐国镇,高黎,易俊林,黄晓东,王凯,张世平,曲媛,肖建平. 蝶窦原发恶性肿瘤16例治疗分析[J]. 中华放射肿瘤学杂志, 2015, 24(6): 671-674. DOI: 10.3760/cma.j.issn.1004-4221.2015.06.016
作者姓名:刘志萍  罗京伟  徐国镇  高黎  易俊林  黄晓东  王凯  张世平  曲媛  肖建平
作者单位:100021 北京,中国医学科学院北京协和医学院肿瘤医院肿瘤研究所放疗科(刘志萍为在读博士研究生,原工作单位为哈尔滨医科大学附属第一医院肿瘤科)
基金项目:中国医药卫生事业发展基金(2009-05)
摘    要:目的 分析原发蝶窦恶性肿瘤治疗结果。方法 回顾分析2000—2013年我院收治的原发蝶窦恶性肿瘤16例。初诊无颈部淋巴结发生转移。ⅣA期1例, ⅣB期15例。治疗方法包括手术+放疗11例、单纯手术1例、单纯放疗3例、单纯化疗1例。手术全部为减瘤手术。放疗中位剂量69.96 Gy (56.00~ 80.56 Gy)。结果 全组3年LC、DMFS、DFS、DSS分别为67%、69%、44%、58%, 减瘤术+放疗组分别为67%、55%、30%、41%。全部保留眶内容物及颅底。全组LR率25%, 远处转移率37%, 淋巴结复发率6%。预后分析未见与LC率及DSS相关因素。结论 蝶窦肿瘤经减瘤手术+术后放疗在保留眼眶及颅底前提下能取得良好疗效。蝶窦肿瘤治疗后淋巴结复发率低, 临床不建议常规颈部淋巴结预防照射。

关 键 词:蝶窦肿瘤/放射疗法  蝶窦肿瘤/外科学  失败模式  
收稿时间:2015-01-10

Treatment of primary sphenoid sinus malignancies:an analysis of 16 patients
Liu Zhiping,Luo Jingwei,Xu Guozhen,Gao Li,Yi Junlin,Huang Xiaodong,Wang Kai,Zhang Shiping,Qu Yuan,Xiao Jianping. Treatment of primary sphenoid sinus malignancies:an analysis of 16 patients[J]. Chinese Journal of Radiation Oncology, 2015, 24(6): 671-674. DOI: 10.3760/cma.j.issn.1004-4221.2015.06.016
Authors:Liu Zhiping  Luo Jingwei  Xu Guozhen  Gao Li  Yi Junlin  Huang Xiaodong  Wang Kai  Zhang Shiping  Qu Yuan  Xiao Jianping
Affiliation:Department of Radiation Oncology,Cancer Hospital,Chinese Academy of Medical Science,Peking Union Medical College,Beijing 100021,China
Abstract:Objective To analyze the treatment outcomes of patients with primary sphenoid sinus malignancies. Methods Sixteen patients with primary sphenoid sinus malignancies admitted to our hospital from 2000 to 2013 were analyzed retrospectively. No patients were newly diagnosed with cervical lymph node metastasis. One patient had stage ⅣA disease, while fifteen had stage ⅣB disease. Eleven patients received surgery followed by radiotherapy, one surgery alone, three radiotherapy alone, and one chemotherapy alone.All surgeries were cytoreductive. The median dose of radiotherapy was 69.96 Gy (56.00-80.56 Gy). Results
The 3-year local control (LC), distant metastasis-free survival (DMFS), disease-free survival (DFS), and disease-specific survival (DSS) rates were 67%, 69%, 44%, and 58%, respectively, in all patients, and 67%, 55%, 30%, and 41%, respectively, in patients treated with cytoreductive surgery followed by radiotherapy. All orbital contents and skull base were preserved. In all patients, the local recurrence, distant metastasis, and lymph node recurrence rates were 25%, 37%, and 6%, respectively. There were no independent predictors for the LC and DSS rates based on the prognostic analysis. Conclusions With the orbital contents and skull base preserved, the cytoreductive surgery followed by radiotherapy yields satisfactory outcomes and a low lymph node recurrence rate in the treatment of sphenoid sinus malignancies. The prophylactic irradiation of cervical lymph nodes is not recommended in clinical practice.
Keywords:Sphenoid sinus neoplasms/radiotherapy  Sphenoid sinus neoplasms/surgery  Failure mode  
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号